Literature DB >> 12740594

Glutamatergic mechanisms in addiction.

T M Tzschentke1, W J Schmidt.   

Abstract

Traditionally, addiction research in neuroscience has focused on mechanisms involving dopamine and endogenous opioids. More recently, it has been realized that glutamate also plays a central role in processes underlying the development and maintenance of addiction. These processes include reinforcement, sensitization, habit learning and reinforcement learning, context conditioning, craving and relapse. In the past few years, some major advances have been made in the understanding of how glutamate acts and interacts with other transmitters (in particular, dopamine) in the context of processes underlying addiction. It appears that while many actions of glutamate derive their importance from a stimulatory interaction with the dopaminergic system, there are some glutamatergic mechanisms that contribute to addiction independent of dopaminergic systems. Among those, context-specific aspects of behavioral determinants (ie control over behavior by conditioned stimuli) appear to depend heavily on glutamatergic transmission. A better understanding of the underlying mechanisms might open new avenues to the treatment of addiction, in particular regarding relapse prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740594     DOI: 10.1038/sj.mp.4001269

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  98 in total

1.  Blockade of mGluR5 in the nucleus accumbens shell but not core attenuates heroin seeking behavior in rats.

Authors:  Zhong-ze Lou; Ling-hong Chen; Hui-feng Liu; Lie-min Ruan; Wen-hua Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-11-17       Impact factor: 6.150

Review 2.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.

Authors:  M Foster Olive
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

4.  Corticostriatal Afferents Modulate Responsiveness to Psychostimulant Drugs and Drug-Associated Stimuli.

Authors:  K A Kerstetter; A M Wunsch; K G Nakata; E Donckels; J F Neumaier; Susan M Ferguson
Journal:  Neuropsychopharmacology       Date:  2015-08-20       Impact factor: 7.853

5.  Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.

Authors:  Yoichi Kawasaki; Chunyu Jin; Katsuya Suemaru; Hiromu Kawasaki; Kazuhiko Shibata; Tominari Choshi; Satoshi Hibino; Yutaka Gomita; Hiroaki Araki
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 6.  Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications.

Authors:  Daniela Jezova
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

7.  Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse.

Authors:  Carles Sanchis-Segura; Thilo Borchardt; Valentina Vengeliene; Tarek Zghoul; Daniel Bachteler; Peter Gass; Rolf Sprengel; Rainer Spanagel
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

Review 8.  Adaptive plasticity of NMDA receptors and dendritic spines: implications for enhanced vulnerability of the adolescent brain to alcohol addiction.

Authors:  Ezekiel P Carpenter-Hyland; L Judson Chandler
Journal:  Pharmacol Biochem Behav       Date:  2007-01-23       Impact factor: 3.533

9.  Sensitizing regimens of (+/-)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat.

Authors:  K T Ball; C L Wellman; E Fortenberry; G V Rebec
Journal:  Neuroscience       Date:  2009-02-21       Impact factor: 3.590

10.  Riluzole and D-amphetamine interactions in humans.

Authors:  Mehmet Sofuoglu; Andrew J Waters; Marc Mooney; Thomas Kosten
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-05-18       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.